aTyr Pharma | LIFE

Stock Price
0.39
Daily Change
0 0%
Monthly
-25.03%
Yearly
-63.98%
Q3 Forecast
0.42



Peers Price Chg Day Year Date
Ardelyx 3.40 -0.12 -3.41% -47.04% Sep/15
Biogen 216.17 -1.19 -0.55% 50.45% Sep/15
Bristol-Myers Squibb 63.73 -0.37 -0.58% 37.53% Sep/15
Clal Biotechnology 24.50 -1.20 -4.67% -39.36% Sep/14
Compugen 750.40 1.80 0.24% 66.53% Sep/14
Cipla 1,350.10 -15.90 -1.16% -13.40% Sep/15
Curis 1.13 0.01 0.89% -96.70% Sep/15
CSL 174.26 2.69 1.57% -13.69% Sep/15
Lakefront Biotherapeutics 23.88 0.52 2.23% -11.03% Sep/15
Grifols 7.36 -0.12 -1.60% -25.13% Sep/15


aTyr Pharma traded at $0.39 this Tuesday September 15th. Looking back, over the last four weeks, aTyr Pharma lost 25.03 percent. Over the last 12 months, its price fell by 63.98 percent. Looking ahead, we forecast aTyr Pharma to be priced at 0.42 by the end of this quarter and at 0.39 in one year, according to Trading Economics global macro models projections and analysts expectations.

aTyr Pharma Inc is a United States-based biotechnology company. The Company engaged in the development of medicines based on biology. The Company’s research and development efforts are concentrated on a new discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases.